All changes for the tissue central nervous system (737)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA210
Rho family GTPase 1
Molecular
brain
Human
RND1
10.0% Decrease Gene Expression Level
DAA209
Rho-related BTB domain containing 3
Molecular
brain
Human
RHOBTB3
25.0% Increase Gene Expression Level
DAA107
ring finger protein 19B
Molecular
brain
Human
RNF19B
11.0% Decrease Gene Expression Level
DAA211
RNA binding motif protein 38
Molecular
brain
Human
RBM38
12.0% Increase Gene Expression Level
DAA212
RUN domain containing 3A
Molecular
brain
Human
RUNDC3A
5.0% Decrease Gene Expression Level
DAA215
S100 calcium binding protein B
Molecular
brain
Human
S100B
11.0% Increase Gene Expression Level
DAA219
selenium binding protein 1
Molecular
brain
Human
SELENBP1
7.0% Increase Gene Expression Level
DAA222
selenophosphate synthetase 1
Molecular
brain
Human
SEPHS1
12.0% Increase Gene Expression Level
DAA220
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
Molecular
brain
Human
SEMA6A
8.0% Increase Gene Expression Level
DAA229
serine peptidase inhibitor, Kunitz type, 2
Molecular
brain
Human
SPINT2
3.0% Decrease Gene Expression Level
DAA223
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member
Molecular
brain
Human
SERPINF1
7.0% Decrease Gene Expression Level
DAA216
seryl-tRNA synthetase
Molecular
brain
Human
SARS
10.0% Decrease Gene Expression Level
DAA236
transcription factor 12
Molecular
brain
Human
TCF12
7.0% Increase Gene Expression Level
DAA217
sodium channel, voltage-gated, type II, beta
Molecular
brain
Human
SCN2B
50.0% Decrease Gene Expression Level
DAA225
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
Molecular
brain
Human
SLC17A7
9.0% Decrease Gene Expression Level
DAA226
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
Molecular
brain
Human
SLC25A4
9.0% Decrease Gene Expression Level
DAA166
solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1
Molecular
brain
Human
SLC2A3P1
17.0% Decrease Gene Expression Level
DAA228
sorting nexin 3
Molecular
brain
Human
SNX3
5.0% Decrease Gene Expression Level
DAA766
Speech production problems
Psychological
brain
Human
—
—
DAA224
S-phase kinase-associated protein 1
Molecular
brain
Human
SKP1
4.0% Decrease Gene Expression Level
DAA67
sphingosine-1-phosphate receptor 1
Molecular
brain
Human
S1PR1
27.0% Increase Gene Expression Level
DAA230
spondin 1, extracellular matrix protein
Molecular
brain
Human
SPON1
21.0% Increase Gene Expression Level
DAA231
stathmin-like 2
Molecular
brain
Human
STMN2
6.0% Decrease Gene Expression Level
DAA627
Stroke
Pathological
brain
Human
—
SeriesMorbidity
DAA1027
Stroke (Female)
Pathological
brain
Human
—
SeriesIncidence
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA210 | Rho family GTPase 1 | Molecular | brain | Human | RND1 | 10.0% Decrease Gene Expression Level | |
DAA209 | Rho-related BTB domain containing 3 | Molecular | brain | Human | RHOBTB3 | 25.0% Increase Gene Expression Level | |
DAA107 | ring finger protein 19B | Molecular | brain | Human | RNF19B | 11.0% Decrease Gene Expression Level | |
DAA211 | RNA binding motif protein 38 | Molecular | brain | Human | RBM38 | 12.0% Increase Gene Expression Level | |
DAA212 | RUN domain containing 3A | Molecular | brain | Human | RUNDC3A | 5.0% Decrease Gene Expression Level | |
DAA215 | S100 calcium binding protein B | Molecular | brain | Human | S100B | 11.0% Increase Gene Expression Level | |
DAA219 | selenium binding protein 1 | Molecular | brain | Human | SELENBP1 | 7.0% Increase Gene Expression Level | |
DAA222 | selenophosphate synthetase 1 | Molecular | brain | Human | SEPHS1 | 12.0% Increase Gene Expression Level | |
DAA220 | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | Molecular | brain | Human | SEMA6A | 8.0% Increase Gene Expression Level | |
DAA229 | serine peptidase inhibitor, Kunitz type, 2 | Molecular | brain | Human | SPINT2 | 3.0% Decrease Gene Expression Level | |
DAA223 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member | Molecular | brain | Human | SERPINF1 | 7.0% Decrease Gene Expression Level | |
DAA216 | seryl-tRNA synthetase | Molecular | brain | Human | SARS | 10.0% Decrease Gene Expression Level | |
DAA236 | transcription factor 12 | Molecular | brain | Human | TCF12 | 7.0% Increase Gene Expression Level | |
DAA217 | sodium channel, voltage-gated, type II, beta | Molecular | brain | Human | SCN2B | 50.0% Decrease Gene Expression Level | |
DAA225 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 | Molecular | brain | Human | SLC17A7 | 9.0% Decrease Gene Expression Level | |
DAA226 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Molecular | brain | Human | SLC25A4 | 9.0% Decrease Gene Expression Level | |
DAA166 | solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1 | Molecular | brain | Human | SLC2A3P1 | 17.0% Decrease Gene Expression Level | |
DAA228 | sorting nexin 3 | Molecular | brain | Human | SNX3 | 5.0% Decrease Gene Expression Level | |
DAA766 | Speech production problems | Psychological | brain | Human | — | — | |
DAA224 | S-phase kinase-associated protein 1 | Molecular | brain | Human | SKP1 | 4.0% Decrease Gene Expression Level | |
DAA67 | sphingosine-1-phosphate receptor 1 | Molecular | brain | Human | S1PR1 | 27.0% Increase Gene Expression Level | |
DAA230 | spondin 1, extracellular matrix protein | Molecular | brain | Human | SPON1 | 21.0% Increase Gene Expression Level | |
DAA231 | stathmin-like 2 | Molecular | brain | Human | STMN2 | 6.0% Decrease Gene Expression Level | |
DAA627 | Stroke | Pathological | brain | Human | — | SeriesMorbidity | |
DAA1027 | Stroke (Female) | Pathological | brain | Human | — | SeriesIncidence |